Northwestern University: Ovarian Neoplasms trials

The registry lists 11 Ovarian Neoplasms studies with Northwestern University as lead sponsor. 3 are open to participants now and 1 have results posted.

Phase 2 3Phase 3 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Alternate Day Fasting After Surgery for Patients Undergoing ChemotherapyRecruitingNCT05990426Not applicable
• CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid TumorsRecruitingNCT05733000Phase 2
• Specimen and Data Study for Ovarian Cancer Early Detection and PreventionRecruitingNCT00005095
• Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT04753216Phase 2Results posted
• GYNecologic Cancer-Related COGnitive ImpairmentCompletedNCT06662435Not applicable
• Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)Active, not recruitingNCT05743517Not applicable
• Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian CancerCompletedNCT05092763Not applicable
• The Effects Of Yoga On Quality Of Life Among A Population Of Ovarian/ Fallopian Tube/ Primary Peritoneal Cancer Patients Receiving Chemotherapy: A Feasibility StudyTerminatedNCT01743547Not applicable
• Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial CancerTerminatedNCT00006262Phase 2
• Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial CancerCompletedNCT00004909
• Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving ChemotherapyCompletedNCT00004166Phase 3